CD14 is a coreceptor of Toll-like receptors 7 and 9.

Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol (2012) 2.00

Toll-like receptor signaling pathways. Front Immunol (2014) 1.58

DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc Natl Acad Sci U S A (2012) 1.29

Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol (2011) 1.14

Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol (2015) 1.10

Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. Oncoimmunology (2012) 1.10

Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol (2013) 1.08

Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb Perspect Biol (2014) 1.07

Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14. Arthritis Rheum (2012) 1.06

Human cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression. PLoS One (2012) 0.99

DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J (2011) 0.97

Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Th1 responses that are contact-dependent and mediated by IL-15. J Leukoc Biol (2011) 0.96

A method to resolve the composition of heterogeneous affinity-purified protein complexes assembled around a common protein by chemical cross-linking, gel electrophoresis and mass spectrometry. Nat Protoc (2012) 0.95

Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humans. J Immunol (2011) 0.93

Vascular dysfunction following polymicrobial sepsis: role of pattern recognition receptors. PLoS One (2012) 0.93

Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology (2012) 0.92

Fungal glycans and the innate immune recognition. Front Cell Infect Microbiol (2014) 0.91

RNA mediated Toll-like receptor stimulation in health and disease. RNA Biol (2012) 0.90

APOε4 is associated with enhanced in vivo innate immune responses in human subjects. J Allergy Clin Immunol (2014) 0.90

Molecular mechanisms of regulation of Toll-like receptor signaling. J Leukoc Biol (2016) 0.89

CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers. J Biol Chem (2013) 0.88

TLR2 ligands induce NF-κB activation from endosomal compartments of human monocytes. PLoS One (2013) 0.86

Toll-like receptor and accessory molecule mRNA expression in humans and mice as well as in murine autoimmunity, transient inflammation, and progressive fibrosis. Int J Mol Sci (2013) 0.86

CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance. Proc Natl Acad Sci U S A (2015) 0.86

Emerging principles governing signal transduction by pattern-recognition receptors. Cold Spring Harb Perspect Biol (2014) 0.85

Toll-like Receptors in the Vascular System: Sensing the Dangers Within. Pharmacol Rev (2016) 0.84

Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1α Release. Immunity (2015) 0.84

The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity. Cell Rep (2015) 0.84

Toll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsis. Mediators Inflamm (2013) 0.84

CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A (2015) 0.83

Toll-like receptor 3 (TLR3) signaling requires TLR4 Interactor with leucine-rich REPeats (TRIL). J Biol Chem (2011) 0.83

Porphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection. J Innate Immun (2014) 0.82

Alterations of dendritic cells in sepsis: featured role in immunoparalysis. Biomed Res Int (2015) 0.82

Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9. Lab Invest (2014) 0.82

Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies. PLoS One (2013) 0.82

Mechanisms and pathways of innate immune activation and regulation in health and cancer. Hum Vaccin Immunother (2014) 0.82

The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load. Clin Exp Immunol (2015) 0.82

CD19 controls Toll-like receptor 9 responses in human B cells. J Allergy Clin Immunol (2015) 0.82

Evolving Bacterial Envelopes and Plasticity of TLR2-Dependent Responses: Basic Research and Translational Opportunities. Front Immunol (2013) 0.81

Novel strategies for targeting innate immune responses to influenza. Mucosal Immunol (2016) 0.81

Novel synthetic toll-like receptor 4/MD2 ligands attenuate sterile inflammation. J Pharmacol Exp Ther (2014) 0.81

The Gdac1 locus modifies spontaneous and Salmonella-induced colitis in mice deficient in either Gpx2 or Gpx1 gene. Free Radic Biol Med (2013) 0.80

Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease. Arthritis Res Ther (2015) 0.80

No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis. PLoS One (2014) 0.80

TLR9 activation is triggered by the excess of stimulatory versus inhibitory motifs present in Trypanosomatidae DNA. PLoS Negl Trop Dis (2014) 0.79

Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells. J Biol Chem (2012) 0.79

Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium. Mediators Inflamm (2013) 0.78

CD14 influences host immune responses and alternative activation of macrophages during Schistosoma mansoni infection. Infect Immun (2014) 0.78

SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7. J Immunol (2015) 0.77

TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection. Proc Natl Acad Sci U S A (2015) 0.77

Probing the cell membrane by magnetic particle actuation and Euler angle tracking. Biophys J (2012) 0.77

Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4-MD2 Complex. J Infect Dis (2016) 0.76

A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway. PLoS One (2015) 0.76

Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids. Sci Rep (2015) 0.75

Identification of pro-inflammatory CD205(+) macrophages in livers of hepatitis B virus transgenic mice and patients with chronic hepatitis B. Sci Rep (2017) 0.75

Toll2011 at Lago di Garda: studying danger sensors by the guard towers at the lake. Nat Immunol (2011) 0.75

Non-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching. J Immunol Res (2015) 0.75

Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing. Exp Eye Res (2016) 0.75

Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands. Sci Rep (2017) 0.75

Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities. Cancer Immunol Immunother (2017) 0.75

Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65

Pattern recognition receptors and inflammation. Cell (2010) 21.05

Proteome survey reveals modularity of the yeast cell machinery. Nature (2006) 20.77

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell (2002) 18.22

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 16.26

Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem (2003) 13.58

Toll-like receptors in innate immunity. Int Immunol (2005) 12.24

Origin and physiological roles of inflammation. Nature (2008) 11.68

Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell (2008) 9.59

Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A (2004) 9.00

The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature (2009) 8.99

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature (2007) 8.88

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8.33

The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A (2004) 7.51

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med (2003) 7.26

A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol (2004) 7.23

Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell (2007) 6.84

Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell (2007) 6.55

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell (2003) 5.89

Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature (2005) 5.72

Peroxisomes are signaling platforms for antiviral innate immunity. Cell (2010) 5.24

Intracellular toll-like receptors. Immunity (2010) 4.66

Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature (2010) 4.61

Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science (2008) 4.41

CD14 is a pattern recognition receptor. Immunity (1994) 3.79

The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol (2007) 3.72

Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol (2008) 3.61

Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem (2002) 3.58

An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat Methods (2006) 3.38

The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev (2008) 3.15

Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol (1999) 2.85

Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity (2006) 2.51

NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol (2009) 2.39

Recognition of viral nucleic acids in innate immunity. Rev Med Virol (2010) 2.33

Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology (2005) 2.24

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J Exp Med (2007) 2.23

Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev (2007) 2.22

Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect (2004) 2.19

CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature (2009) 2.13

Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods (2007) 2.06

The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation. Blood (2007) 1.99

Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol (2000) 1.84

TLR accessory molecules. Curr Opin Immunol (2008) 1.84

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J (2008) 1.76

Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids. Arterioscler Thromb Vasc Biol (2008) 1.76

Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J Biol Chem (2005) 1.70

Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem (2000) 1.65

Toll-like receptors as molecular switches. Nat Rev Immunol (2006) 1.60

Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis. J Immunol (1994) 1.42

Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol (2009) 1.28

TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol (2004) 1.23

CD14 signalling in lipid rafts: new ligands and co-receptors. Curr Opin Lipidol (2002) 1.12

A systems view of host defense. Nat Biotechnol (2009) 0.91

The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2. Immunology (2010) 0.87

Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature (2002) 45.19

Proteome survey reveals modularity of the yeast cell machinery. Nature (2006) 20.77

Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med (2013) 9.65

The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol (2007) 8.24

An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 7.93

A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol (2004) 7.23

ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res (2003) 6.86

Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell (2003) 5.44

Peroxisomes are signaling platforms for antiviral innate immunity. Cell (2010) 5.24

The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods (2013) 4.34

Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21

IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol (2011) 4.18

Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol (2010) 3.61

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood (2007) 3.59

RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell (2010) 3.59

A myristoyl/phosphotyrosine switch regulates c-Abl. Cell (2003) 3.48

An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat Methods (2006) 3.38

Target profiling of small molecules by chemical proteomics. Nat Chem Biol (2009) 3.20

RNase P without RNA: identification and functional reconstitution of the human mitochondrial tRNA processing enzyme. Cell (2008) 3.15

Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol (2004) 3.10

Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell (2010) 2.91

Structure-based assembly of protein complexes in yeast. Science (2004) 2.89

The aurora B kinase AIR-2 regulates kinetochores during mitosis and is required for separation of homologous Chromosomes during meiosis. Curr Biol (2002) 2.86

Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature (2011) 2.64

A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat Chem Biol (2010) 2.53

The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib. Proc Natl Acad Sci U S A (2007) 2.51

Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell (2008) 2.46

Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45

Rediscovering the sweet spot in drug discovery. Drug Discov Today (2003) 2.45

NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol (2009) 2.39

Genetic and cytological characterization of the recombination protein RAD-51 in Caenorhabditis elegans. Chromosoma (2003) 2.29

Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol Cell (2006) 2.28

Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. EMBO Mol Med (2010) 2.23

Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing. Science (2012) 2.22

RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev Cell (2004) 2.13

Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis. Cell (2011) 2.11

Evidence for a size-sensing mechanism in animal cells. Nat Cell Biol (2004) 2.09

Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods (2007) 2.06

Meiotic chromosome homology search involves modifications of the nuclear envelope protein Matefin/SUN-1. Cell (2009) 1.99

c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol Cell Biol (2002) 1.98

Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol (2005) 1.96

Autoinhibition of c-Abl. Cell (2002) 1.93

Viral immune modulators perturb the human molecular network by common and unique strategies. Nature (2012) 1.86

Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78

BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nat Chem Biol (2012) 1.77

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J (2008) 1.76

Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids. Arterioscler Thromb Vasc Biol (2008) 1.76

Brain-wide 3D imaging of neuronal activity in Caenorhabditis elegans with sculpted light. Nat Methods (2013) 1.73

Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun (2004) 1.73

PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med (2012) 1.67

A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. Nat Chem Biol (2011) 1.65

Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J (2006) 1.64

Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leuk Lymphoma (2008) 1.63

SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations. Hum Mutat (2012) 1.61

Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins. Nature (2013) 1.58

From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology (2008) 1.57

Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe (2010) 1.56

A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol (2010) 1.47

Aspiration pneumonitis primes the host for an exaggerated inflammatory response during pneumonia. Crit Care Med (2005) 1.46

Targeted gene knockout reveals a role in meiotic recombination for ZHP-3, a Zip3-related protein in Caenorhabditis elegans. Mol Cell Biol (2004) 1.45

Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia? Biochem Pharmacol (2007) 1.44

c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. EMBO J (2002) 1.41

Proteomic analysis of seminal plasma from infertile patients with oligoasthenoteratozoospermia due to oxidative stress and comparison with fertile volunteers. Fertil Steril (2013) 1.41

Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. Nephrol Dial Transplant (2008) 1.37

Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci U S A (2009) 1.37

Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathog (2011) 1.36